| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1210/JC.2007-2437 |
| P8608 | Fatcat ID | release_aiobyktllzcejerbnt6l5mgq4y |
| P698 | PubMed publication ID | 18252793 |
| P5875 | ResearchGate publication ID | 5599060 |
| P50 | author | Victor Montori | Q7926167 |
| Lourdes Ibañez | Q59519339 | ||
| Lourdes Ibáñez | Q90844952 | ||
| Brian A Swiglo | Q125192699 | ||
| P2093 | author name string | R Jeffrey Chang | |
| Robert L Rosenfield | |||
| David A Ehrmann | |||
| Kathryn A Martin | |||
| Rogerio A Lobo | |||
| Jerry Shapiro | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hirsutism | Q1620594 |
| P304 | page(s) | 1105-1120 | |
| P577 | publication date | 2008-02-05 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline | |
| P478 | volume | 93 |
| Q83412138 | A premenopausal woman with virilization secondary to an ovarian Leydig cell tumor |
| Q37973246 | A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence |
| Q90599881 | Adolescent polycystic ovary syndrome according to the international evidence-based guideline |
| Q35442243 | Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood |
| Q33587839 | Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis |
| Q30419133 | Altering hirsutism through ovulation induction in women with polycystic ovary syndrome |
| Q46552680 | An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence |
| Q34457689 | An interesting cause of hyperandrogenemic hirsutism |
| Q37968636 | An overview of unwanted female hair |
| Q47605668 | Androgens trigger different growth responses in genetically identical human hair follicles in organ culture that reflect their epigenetic diversity in life |
| Q84474168 | Author'S reply |
| Q29248890 | CLINICAL PRACTICE. Polycystic Ovary Syndrome |
| Q49587532 | Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis |
| Q37149593 | Clinical review: Adolescent anovulation: maturational mechanisms and implications |
| Q38796542 | Comparison of myo-inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: A randomized controlled clinical trial |
| Q33539381 | Comprehensive clinical management of hirsutism |
| Q51031432 | Congenital Adrenal Hyperplasia. |
| Q24614223 | Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline |
| Q36802670 | Congenital adrenal hyperplasia: an update in children |
| Q27007070 | Dermatosis associated with menopause |
| Q35591505 | Diagnosis and challenges of polycystic ovary syndrome in adolescence |
| Q33587845 | Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline |
| Q38111033 | Differences in the management of adolescents with polycystic ovary syndrome across pediatric specialties. |
| Q47930804 | Does insulin resistance increase thyroid volume in patients with polycystic ovary syndrome? |
| Q34018185 | Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome |
| Q33640640 | Endocrine evaluation of hirsutism |
| Q88035524 | Endocrine evaluation of hirsutism |
| Q37953819 | Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. |
| Q55395851 | Evaluation and Treatment of Hirsutism in Premenopausal Women. |
| Q38018780 | Family planning 2011: better use of existing methods, new strategies and more informed choices for female contraception |
| Q36449581 | Fine-needle aspiration cytology of ovarian steroid cell tumor: A rare case report |
| Q33774743 | Flutamide: hirsutism in women |
| Q34422575 | Hirsutism: an evidence-based treatment update |
| Q27014813 | Hirsutism: diagnosis and treatment |
| Q33564154 | Hirsutism: evaluation and treatment |
| Q35026034 | Hirsutism: evaluation and treatment: a reader's dilemma |
| Q33525337 | Hirsutism: from Brazil to a place near you. |
| Q37869200 | How should postmenopausal androgen excess be evaluated? |
| Q26822584 | Hyperandrogenism after menopause |
| Q43630424 | Hyperandrogenism in post-menopausal women: a diagnosis challenge |
| Q33893011 | Identification and treatment of metabolic complications in pediatric obesity |
| Q24186393 | Interventions for hirsutism (excluding laser and photoepilation therapy alone) |
| Q24201916 | Interventions for hirsutism excluding laser and photoepilation therapy |
| Q35927890 | Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments |
| Q35743293 | Is the endocrine research pipeline broken? A systematic evaluation of the Endocrine Society clinical practice guidelines and trial registration |
| Q51291360 | Levonorgestrel-Releasing Intrauterine System for Women With Polycystic Ovary Syndrome: Metabolic and Clinical Effects. |
| Q46066318 | Low-dose flutamide for women with androgen excess: anti-androgenic efficacy and hepatic safety |
| Q27025013 | Management of adolescents with congenital adrenal hyperplasia |
| Q41405329 | Marked hyperandrogenicity in a 60-year-old woman |
| Q40255457 | Maternal hirsutism and autism spectrum disorders in offspring. |
| Q90594331 | Menstrual patterns and self-reported hirsutism as assessed via the modified Ferriman-Gallwey scale: A cross-sectional study |
| Q38245312 | Metformin in women with PCOS, cons. |
| Q48006996 | Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome |
| Q44402842 | No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours |
| Q38535106 | Optimal management of polycystic ovary syndrome in adolescence |
| Q42974919 | Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne |
| Q93186492 | Polycystic Ovary Syndrome in Adolescents: Challenges in Diagnosis and Treatment |
| Q65954080 | Polycystic Ovary Syndrome: Impact of Lipotoxicity on Metabolic and Reproductive Health |
| Q92437260 | Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls |
| Q47102932 | Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies |
| Q37857735 | Polycystic ovary syndrome: a dermatologic approach |
| Q35639510 | Polycystic ovary syndrome: chemical pharmacotherapy |
| Q37832125 | Polycystic ovary syndrome: etiology, pathogenesis and diagnosis |
| Q46376499 | Possible efficacy of Lavender and Tea tree oils in the treatment of young women affected by mild idiopathic hirsutism. |
| Q39836227 | Prescribing patterns of combined hormonal products containing cyproterone acetate, levonorgestrel and drospirenone in the UK. |
| Q37703775 | Relationship Between the Clinical and Biochemical Findings of Polycystic Ovary Syndrome and Depression and Anxiety |
| Q28390200 | Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome |
| Q36266426 | Severe Facial Hirsutism Following Isotretinoin Therapy: An Under-reported Entity |
| Q30423117 | Should all women with PCOS be treated for insulin resistance? |
| Q35233754 | State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS). |
| Q36691812 | Steroid cell tumor of the ovary in an adolescent: a rare case report |
| Q41640666 | The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited |
| Q28553212 | The Presence of Clitoromegaly in the Nonclassical Form of 21-Hydroxylase Deficiency Could Be Partially Modulated by the CAG Polymorphic Tract of the Androgen Receptor Gene |
| Q37488921 | The effect of fennel (Foeniculum vulgare) gel 3% in decreasing hair thickness in idiopathic mild to moderate hirsutism, A randomized placebo controlled clinical trial |
| Q37527874 | The frequency of polycystic ovary syndrome in young reproductive females in Qatar |
| Q47704410 | Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients. |
| Q48071988 | Therapeutic, prophylactic, untoward, and contraceptive effects of combined oral contraceptives: catholic teaching, natural law, and the principle of double effect when deciding to prescribe and use. |
| Q42958598 | Therapy: Low-dose flutamide for hirsutism: into the limelight, at last |
| Q35015784 | Total testosterone levels are often more than three times elevated in patients with androgen-secreting tumours. |
| Q34574136 | Treatment options for polycystic ovary syndrome |
| Q37591857 | Two patients with marginal symptoms showing hyperthecosis at the edge of malignancy: Presentation of two cases |
| Q64077862 | Update on Management of Polycystic Ovarian Syndrome for Dermatologists |
| Q92193941 | Use of Successive Pharmacologic Hormone Suppression Testing for a Severe Presentation of Adolescent Polycystic Ovarian Syndrome: A Case Report |
| Q37848915 | Use of metformin in pediatric age. |
| Q90607820 | Virilizing Steroid Cell Tumor of the Ovary: Successful Surgical Management of an Enigma |
| Q38633475 | What does a diagnostic label of 'polycystic ovary syndrome' really mean in adolescence? A review of current practice recommendations |
Search more.